Archive · 24 Jun 2025
Novo Nordisk to Launch Wegovy Weight Loss Drug in India
A Danish company called Novo Nordisk is bringing a weight loss shot called Wegovy to India.
This shot, often called a "skinny jab," uses the same ingredient as the diabetes drug Ozempic.
Celebrities have helped make it popular.
It comes in a pen with doses that cost between ₹17,345 and ₹26,050 a month.
Another similar drug, Mounjaro, is already available in India from a different company.
These medications work by reducing how much you eat and helping you lose weight.
Novo Nordisk to launch Wegovy, an injectable weight loss medication, in India.
Wegovy contains semaglutide, the same active ingredient as the diabetes drug Ozempic.
The injectable product is delivered via a 4-dose pen and is available at various strengths.
Pricing for Wegovy ranges from ₹17,345 to ₹26,050 per month depending on dosage.
Eli Lilly launched its similar weight loss medication Mounjaro in India approximately three months ago.
- Who
- Novo Nordisk
- What
- Novo Nordisk is launching Wegovy, a weight loss injectable.
- When
- Launching on Tuesday, June 24, 2025
- Where
- India
- Why
- To offer a weight loss medication to the Indian market.
Potential Market Challenges
Market Competition
Patent Infringement
Potential Market Challenges
Generic manufacturers may launch competing products after the patent expires.
Market Competition
Novo Nordisk has patent infringement suits against local companies.
- Drug Name
- Wegovy
- Active Ingredient
- Semaglutide
- Manufacturer
- Novo Nordisk
- Delivery
- 4-dose pen
- Pricing
- ₹17,345 to ₹26,050 per month
- Similar Drug
- Mounjaro